Almost all (16 of 17) patients presenting a luminal A subtype in the tumor biopsy showed at least one DTC-expressing HER2 positivity and 41% showed a discordance for ER in this subtype, meaning that ER+ DTCs were expected but not present. Here, ERBB2 is linked to neoplasm.